Neuroprotective Efficiency of Cyclosporine After Traumatic Brain Injury in Rats

Area of Science:

• Neuroscience
• Pharmacology
• Trauma Research

Background:

• Traumatic brain injury (TBI) leads to significant neuronal damage.
• Mitochondrial dysfunction plays a key role in TBI-induced neurodegeneration.
• Current treatments for TBI have limited efficacy in preventing secondary injury cascades.

Purpose of the Study:

• To investigate the neuroprotective potential of systemic cyclosporine (Cyclosporin A) administration following experimental TBI in rats.
• To assess the impact of cyclosporine on brain edema and lipid peroxidation post-TBI.
• To evaluate the effect of cyclosporine on ultrastructural neurodegeneration.

Main Methods:

• A modified Feeney method was employed to induce TBI in male Sprague Dawley rats.
• Cyclosporine (20 mg/kg) was administered intraperitoneally post-injury.
• Brain edema was measured using wet-dry weight, lipid peroxidation was assessed, and histological changes were examined via transmission electron microscopy.

Main Results:

• Cyclosporine treatment significantly reduced brain edema levels compared to controls.
• A significant decrease in lipid peroxidation ratio was observed in cyclosporine-treated rats.
• Ultrastructural analysis revealed significant neuroprotective effects of cyclosporine, reducing neurodegeneration.

Conclusions:

• Systemic administration of cyclosporine demonstrates significant neuroprotective effects after TBI in rats.
• Cyclosporine effectively mitigates brain edema and lipid peroxidation, key indicators of TBI severity.
• The findings suggest that modulating mitochondrial permeability transition pore opening by cyclosporine is a viable therapeutic strategy for TBI.